Structure-Guided Design of Partial Agonists at an Opioid Receptor

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Chronic pain and opioid overdose deaths necessitate alternative analgesics to the μ opioid receptor (μOR).
• The δ opioid receptor (δOR) offers a potential target for non-addictive pain relief, but early agonists caused seizures.
• Partial δOR agonists may provide safer analgesia, yet their mechanism remains unclear.

Purpose of the Study:

• To design and characterize a novel selective δOR partial agonist using a structure-based approach.
• To investigate the molecular mechanism of partial agonism at the δOR, focusing on sodium pocket engagement.
• To evaluate the analgesic efficacy and safety profile of the developed ligand in preclinical models.

Main Methods:

• Structure-based drug design and computational prediction of a bitopic ligand (C6-Quino).
• In vitro functional assays to assess δOR activity at G-protein and arrestin pathways.
• Single particle cryo-electron microscopy (cryo-EM) to analyze ligand-receptor interaction.
• In vivo studies in chronic pain models to evaluate analgesic effects and safety.

Main Results:

• C6-Quino was identified as a selective δOR partial agonist with dual pathway activity.
• Cryo-EM confirmed C6-Quino's interaction with the δOR sodium binding pocket.
• C6-Quino exhibited oral bioavailability and potent analgesic effects in multiple chronic pain models.
• Crucially, C6-Quino did not induce μOR-related hyperlocomotion/respiratory depression or δOR-related convulsions at analgesic doses.

Conclusions:

• A novel structure-based strategy successfully yielded a safe and effective δOR partial agonist, C6-Quino.
• This approach provides a blueprint for developing safer analgesics targeting the δOR.
• The findings offer a generalizable method for optimizing the signaling profiles of Class A G protein-coupled receptors (GPCRs).